ABCC1, also known as MRP1, is associated with chemotherapy resistance of prostate, breast, and lung cancers [55,56,57], and ABCG2, which is also known as BCRP, is involved in the chemoresistance of breast cancer and leukemia [50,58]. This evidence concerns the gene ABCC1 and lung carcinoma.